Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

March 23, Epichem Waste to Fuel Licensing Agreement with Thermaquatica

210323_PAA_Epichem_Thermaquatica

Category: News and Announcements 2021By Richard Mollard March 23, 2021

Related posts

May 31, Top 20 Shareholders
June 1, 2021

May 14, Dr Kim Agnew Appointed PI of MPL Dog Cancer Trial
May 14, 2021

April 30, Top 20 Shareholders
May 1, 2021

April 29, Appendix 4C and Quarterly Update
April 29, 2021

April 27, Monepantel Phase IIb Dog Lymphoma Interim Plasma Data
April 27, 2021

April 8, PharmAust Receives $750k R&D Tax Incentive Refund
April 8, 2021

Recent Articles

May 31, Top 20 Shareholders
June 1, 2021
May 14, Dr Kim Agnew Appointed PI of MPL Dog Cancer Trial
May 14, 2021
April 30, Top 20 Shareholders
May 1, 2021
April 29, Appendix 4C and Quarterly Update
April 29, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

$PAA director, Sam Wright was interviewed by @DeeDeeDunleavy on @3AW693 today about the upcoming @FightMND clinical trial

Click on the link below to listen to the audio from 3AW Afternoons with Dee Dee Dunleavy

http://www.mediaportal.com/mp/playnow.aspx?u=156131&p=-2253116180&key=501128643120229355243232291321640229244

#BigFreeze7 #PlayOn #FightMND

Reply on Twitter 1403234254373363714 Retweet on Twitter 14032342543733637144 Like on Twitter 14032342543733637149 Twitter 1403234254373363714

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions